Ageing population, tech drive Japan’s medical device market | Healthcare Asia Magazine
, Japan
399 views
Photo by Natanael Melchor on Unsplash

Ageing population, tech drive Japan’s medical device market

The country is already home to the highest senior population ratio in the world.

Japan’s medical device market is projected to grow by at least 5.5% each year through 2027 mainly driven by its propensity for advanced technologies and an ageing population, according to a report by Fitch Solutions.

Fitch estimated the market is set to expand at a compound annual growth rate of 5.5% in local Japanese yen terms and 5.8% in US dollars between 2022 and 2027, which could push the sector’s size to as high as JPY 4.1t (USD 35.7b) by 2027.

One of the key long-term growth drivers of the market is Japan’s elderly as its share of the total population is projected to surge to 37.5% by 2050 from less than 30% in 2020. Currently, the country is already home to the highest senior population ratio in the world.

Fitch said the increased demand for healthcare services from the growing elderly population for treatments for chronic illnesses and the like, will support the growth of the medical device market.

“Japan’s medical device market is (also) receptive to high-margin and innovative technologies, which will support uptake of modern devices. Increasing demand for healthcare services from the elderly combined with adoption of new technologies will be key growth drivers over our forecast period,” it added.

One factor affecting the sector’s growth, however, is the declining demand for COVID-related medical devices as seen in weak trades of such products.

“Other medical devices and orthopaedics and prosthetics were key import growth drivers in the three months to February 2023, which suggests a recovery in elective procedures that will likely accelerate in the coming months,” Fitch added.

Follow the link for more news on

Pemindaian AI terkini meningkatkan diagnosa di Shin Kong Wu Ho-Su Memorial Hospital

Rumah sakit di Taiwan ini menggunakan teknologi endoskop yang dibantu AI untuk mendeteksi polip dan kamera resolusi tinggi untuk telemedis.

Kejeniusan dalam ‘SuperApps’ untuk perawatan kesehatan adalah akses dan jangkauan

Rumah sakit yang merangkul digitalisasi tetap unggul dalam layanan kesehatan.

Rumah Sakit Kanker Dharmais memimpin inovasi pelayanan kanker di Indonesia

Direktur Utama RS Kanker Dharmais Soeko Werdi Nindito Daroekoesoemo mengungkapkan teknologi canggih dan tujuh program unggulan untuk perawatan kanker.

Healthway Cancer Care Hospital memajukan perawatan holistik dengan harga yang wajar

Rumah sakit mengharapkan program kualitas dan kelangsungan hidup yang melayani keseluruhan perjalanan pasien.

MakatiMed menuju perawatan bedah presisi dengan sistem robotik Da Vinci Xi

Teknologi ini memungkinkan teknik invasif minimal dalam bidang urologi, hepatobilier, kardiovaskular, toraks, kebidanan dan ginekologi, serta bedah umum.

Indonesia memperluas dukungan solusi kesehatan menggunakan AI

Kolaborasi dengan Google Cloud sejalan dengan cetak biru pemerintah untuk transformasi kesehatan digital.

Indonesia merancang rencana induk untuk pengembangan kesehatan terpadu

Rencana induk sektor kesehatan negara (RIBK) selaras dengan mandat Undang-Undang Kesehatan Nomor 17 Tahun 2023.

The Medical City membuka jalan bagi integrasi AI dalam layanan kesehatan lokal dan penelitian dengan Lunit

AI telah diintegrasikan ke dalam layanan mamografi dan rontgen dada di jaringan rumah sakit ini.

Mayapada Healthcare Group meraih prestasi besar di Healthcare Asia Awards 2024

Pendekatan holistik yang dilakukan oleh rumah sakit tersebut mendorongnya maju dan menjadi standar industri.

Rumah Sakit Kanker Dharmais meraih dua kemenangan di Healthcare Asia Awards 2024

Sumber daya manusia yang kompeten, layanan, fasilitas, dan infrastruktur unggul membantu rumah sakit memberikan perawatan pasien yang sangat baik.